Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH

Completed · Not applicable

Conditions studied: Non-alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver

In brief

This single arm interventional cohort study is designed to explore the feasibility of using BT-NCBT-00x to improve liver fat, inflammation, and stiffness in patients diagnosed with NAFLD or NASH over a 3 month intervention.

Key facts

Study ID

NCT05357248

Run by

Better Therapeutics

People needed

22

Starts

2022-04-10

Expected to finish

2022-12-07

Last updated by the study team

2022-12-13

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of NAFLD or NASH
• At least 2 doses of the COVID-19 Vaccine, per self report
• Possession of a smartphone capable of running the Bt_NCBT-00x application
• BMI >/= 30 at the screening visit
• Fibroscan CAP >300 dB/m collected at screening visit
• Completion of baseline MRI-PDFF
• Understand written and spoken english

You may not qualify if…

• Inability to read and understand english
• unstable or life-threatening medical illness
• weight loss of greater than 10lbs within the last 90 days
• pregnant or planning to become pregnant women
• concurrent enrollment in any other interventional clinical trial
• presumed or confirmed COVID-19 diagnosis within 30 days prior to study enrollment
• change in medication regimen of hormonal contraceptives, anti-hyperglycemic medications, mental or emotional disorder medications, corticosteroids, thyroid hormones, Tamoxifen or Methotrexate within 90 days

Where it is running

• Arizona Liver Health — Chandler, Arizona, United States
• Arizona Liver Health — Peoria, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.